188 related articles for article (PubMed ID: 33145987)
1. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.
Shen X; Liu S; Wu C; Wang J; Li J; Chen L
Cancer Med; 2021 Jan; 10(2):462-470. PubMed ID: 33145987
[TBL] [Abstract][Full Text] [Related]
2. Reossification and prognosis following radiotherapy with/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients.
Ouyang H; Han S; Jiang L; Zhuang H; Yang S; Liu Y; Zhang L; Liu X; Wei F; Chen K; Zhou S; Liu Z
Spine J; 2020 Feb; 20(2):283-291. PubMed ID: 31546017
[TBL] [Abstract][Full Text] [Related]
3. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
4. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Solitary Plasmacytoma of Bone in Elderly Patients: A Nomogram and a Risk Classification System for Overall Survival.
Zhang X; Yang J; Tian Z; Khabir Y; Wang D
Biomed Res Int; 2022; 2022():7387416. PubMed ID: 35692586
[TBL] [Abstract][Full Text] [Related]
6. Solitary Plasmacytoma of Bone of the Spine: Results From Surveillance, Epidemiology, and End Results (SEER) Registry.
Wang Y; Li H; Liu C; Chen C; Yan J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E117-E125. PubMed ID: 30005040
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
Knobel D; Zouhair A; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Oner FD; Landmann C; Castelain B; Ozsahin M;
BMC Cancer; 2006 May; 6():118. PubMed ID: 16677383
[TBL] [Abstract][Full Text] [Related]
9. Myeloma of the jaw bones: a clinicopathologic study of 33 cases.
Lae ME; Vencio EF; Inwards CY; Unni KK; Nascimento AG
Head Neck; 2003 May; 25(5):373-81. PubMed ID: 12692874
[TBL] [Abstract][Full Text] [Related]
10. Clinical course and survival in 16 patients with localized plasmacytoma.
Wollersheim HC; Holdrinet RS; Haanen C
Scand J Haematol; 1984 Apr; 32(4):423-8. PubMed ID: 6719045
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy in the treatment of solitary plasmacytoma.
Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.
Li QW; Niu SQ; Wang HY; Wen G; Li YY; Xia YF; Zhang YJ
Asian Pac J Cancer Prev; 2015; 16(9):3741-5. PubMed ID: 25987031
[TBL] [Abstract][Full Text] [Related]
13. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
[TBL] [Abstract][Full Text] [Related]
14. [Solitary plasmacytoma of bone: a clinicopathologic, immunohistochemical and immunoglobulin gene rearrangement study].
Zuo Z; Liu WP; Tang Y; Bi CF; Wang XQ; Zhang WY; Yang QP; Zou LQ
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):177-82. PubMed ID: 20450765
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
[TBL] [Abstract][Full Text] [Related]
16. Solitary plasmacytoma.
Dagan R; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Dec; 32(6):612-7. PubMed ID: 19593082
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoma. Treatment results and conversion to myeloma.
Holland J; Trenkner DA; Wasserman TH; Fineberg B
Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
[TBL] [Abstract][Full Text] [Related]
18. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
